Compared with the general population, individuals with celiac disease were almost twice as likely to have CAD, according to a large retrospective study presented here today at the American College of Cardiology (ACC) 2014 Scientific Sessions . Even patients younger than aged 65 years were at higher risk.
Deborah Ceizler, CDF Chief Development Officer, recently attended the Development of Therapies for Celiac Disease Conference hosted by the Celiac Disease Center at Columbia University. The conference provided a unique opportunity to bring together experts from around the world – physicians, scientists, industry leaders including pharmaceutical, diagnostic, biotechnology and food & agriculture – and patients seeking […]
A new study, with contributions made from two CDF Medical Advisory Board Members, Martin Kagnoff and Joseph A. Murray, has identified antibody biomarkers that can be potentially used to diagnose nonresponsive celiac disease.
Celiac disease, one of the most common autoimmune diseases in the world today, often goes undiagnosed due to asymptomatic patients and many nonspecific symptoms. To diagnose a patient with celiac disease, a positive intestinal biopsy is typically necessary. But when physicians need to decide on whether or not to order a biopsy, they have many […]
Alternatives to gluten are absolutely vital to those diagnosed with celiac disease as the only treatment available currently is a life-long, strict gluten-free diet. Many doctors and nutritionists recommend foods like amaranth, millet, buckwheat, and quinoa as substitutes for wheat and other grains toxic for celiac patients; however, there have been recent laboratory tests that […]
A recent study published by the American Journal of Epidemiology by several scientists including Dr. Peter H. R. Green, the founder of the Columbia University Celiac Disease Center and a Medical Advisory Board member for the Celiac Disease Foundation, has found a link between a particular bacterial strain typically found in the human gut and […]
Celiac disease (CD) is an autoimmune disease associated with small intestinal damage and villous atrophy. It occurs in genetically susceptible people of all ages and can involve a variety of symptoms and can also be asymptomatic. Not every genetically susceptible person gets CD however, most likely signifying that environmental factors influence the disease. Infant feeding […]
Celiac disease (CD) is the most common genetically-induced food intolerance and is thought to be present in about 1% of the world’s population. Many cases of CD go undiagnosed until adulthood but mass screening for CD for the entire population is controversial. Instead of serological (blood serum) screening for CD markers as a first step, […]
There are very few studies that have been done to characterize patients who avoid wheat and/or gluten (PWAWG) in the absence of celiac disease. In a recent study, this previously overlooked group was compared to celiac disease patients and the general public. 84 PWAWGs who had celiac disease ruled out as a diagnosis were examined […]
Alvine Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of autoimmune and gastrointestinal diseases, today announced that the first randomized study patient was dosed in the CeliAction Study™